Sedulo Group Case Studies

A leading pharmaceutical company partnered with Sedulo Group to build a continuous competitive intelligence program tracking innovators, biosimilars, and emerging therapies across the rapidly evolving insulin market. The engagement combined ongoing competitor monitoring, primary intelligence, and quarterly landscape reporting to support stronger portfolio decisions and confident preparation for new market entrants.

A global pharmaceutical company partnered with Sedulo to gain continuous visibility into competitive dynamics across four therapeutic areas. The result was faster BD scouting, clearer portfolio prioritization, and more confident strategic decisions.

A biopharma leader partnered with Sedulo on a multi-year competitive intelligence program to connect early clinical signals with commercial strategy. The engagement delivered continuous insights across 10 rare disease areas, enabling faster decisions, earlier warnings, and confident portfolio planning.